Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
PUT
Radian Group
RDN
$5.18B
| $84K | ﹤0.01% |
4,700
-35,700
| -88% | -$661K |
|
4927
PUT
Snap-on
SNA
$21.2B
| $84K | ﹤0.01% |
500
-1,300
| -72% | -$224K |
|
4928
PUT
Ternium
TX
$9.67B
| $84K | ﹤0.01% |
+3,200
| New | +$79.5K |
|
|
MNTA
4929
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $84K | ﹤0.01% |
6,300
+1,400
| +29% | +$21.9K |
|
|
ATW
4930
CALL
DELISTED
Atwood Oceanics
ATW
| $84K | ﹤0.01% |
8,800
-11,500
| -57% | -$128K |
|
|
CIM
4931
PUT
Chimera Investment
CIM
$1.04B
| $83K | ﹤0.01% |
1,367
-5,300
| -79% | -$295K |
|
4932
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
| $83K | ﹤0.01% |
1,000
| – | – |
|
4933
Syndax Pharmaceuticals
SNDX
$1.69B
| $83K | ﹤0.01% |
6,111
+304
| +5% | +$3.16K |
|
4934
PUT
Sysco
SYY
$40.8B
| $83K | ﹤0.01% |
1,600
-3,700
| -70% | -$196K |
|
|
PETX
4935
DELISTED
Aratana Therapeutics, Inc.
PETX
| $83K | ﹤0.01% |
15,551
+14,312
| +1,155% | +$96.6K |
|
|
LDR
4936
DELISTED
Landauer Inc
LDR
| $83K | ﹤0.01% |
1,698
+1,284
| +310% | +$65K |
|
|
IBTX
4937
DELISTED
Independent Bank Group, Inc.
IBTX
| $83K | ﹤0.01% |
1,286
-99
| -7% | -$6.24K |
|
4938
PUT
ProShares Ultra Silver
AGQ
$1.13B
| $82K | ﹤0.01% |
2,000
-5,000
| -71% | -$192K |
|
4939
PUT
Cardinal Health
CAH
$53.9B
| $82K | ﹤0.01% |
1,000
-6,300
| -86% | -$496K |
|
4940
CALL
Forestar Group
FOR
$1.44B
| $82K | ﹤0.01% |
6,000
-100
| -2% | -$1.31K |
|
4941
iShares US Aerospace & Defense ETF
ITA
$14.2B
| $82K | ﹤0.01% |
1,112
| – | – |
|
4942
Peoples Bancorp
PEBO
$1.5B
| $82K | ﹤0.01% |
2,615
+2,110
| +418% | +$67.4K |
|
4943
PUT
Shopify
SHOP
$152B
| $82K | ﹤0.01% |
12,000
+2,000
| +20% | +$11.5K |
|
4944
CALL
Unisys
UIS
$209M
| $82K | ﹤0.01% |
5,900
-9,700
| -62% | -$134K |
|
|
CHUY
4945
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $82K | ﹤0.01% |
2,749
-929
| -25% | -$27.2K |
|
|
CHS
4946
PUT
DELISTED
Chicos FAS, Inc.
CHS
| $82K | ﹤0.01% |
5,800
+2,900
| +100% | +$40.2K |
|
|
ATRS
4947
DELISTED
Antares Pharma, Inc.
ATRS
| $82K | ﹤0.01% |
28,664
+18,864
| +192% | +$45.4K |
|
|
JUNO
4948
DELISTED
Juno Therapeutics, Inc.
JUNO
| $82K | ﹤0.01% |
3,702
-19,087
| -84% | -$409K |
|
4949
CALL
Adtran
ADTN
$689M
| $81K | ﹤0.01% |
3,900
-800
| -17% | -$17.4K |
|
4950
Anavex Life Sciences
AVXL
$255M
| $81K | ﹤0.01% |
14,280
+13,731
| +2,501% | +$70.9K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.